IndicationsStatusPurposePhase
Unknown StatusTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT00331630Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer